Defunct Company
Total Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
829
NCT04705025
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer
Phase: N/A
Role: Collaborator
Start: Apr 8, 2021
Completion: Mar 30, 2023
NCT04862195
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment
Role: Lead Sponsor
Start: May 15, 2021
Completion: Sep 1, 2022
NCT05032404
Blue Note Therapeutics Product BNT 103 Usability and User Engagement
Start: Sep 1, 2021
Completion: Dec 31, 2021
NCT04857008
BNT001 Digital Therapeutic Feasibility Pilot Study
Start: Oct 8, 2021
Completion: Aug 5, 2022
NCT05227898
Virtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With Cancer
Start: Mar 10, 2022
Completion: Dec 15, 2022
NCT05501171
Psychological Mobile App for Patients With AML
Start: Oct 15, 2022
Completion: Feb 1, 2023
NCT05647785
Long-term Follow-up of RESTORE Study
Start: Oct 31, 2022
Completion: Jun 30, 2023
NCT06491576
A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis
Phase: Phase 1/2
Start: Mar 21, 2023
Completion: Mar 4, 2024